SCHEMBL29644477

SCHEMBL29644477

Cc1cc(NCc2ccncc2)n2nc(C)c(-c3ccc4c(c3)c(C)nn4C)c2n1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 7/20 0.60
ALDH1A1 P00352 8/20 0.50
KDM4E B2RXH2 8/20 0.50
MAPT P10636 6/20 0.50
NPSR1 Q6W5P4 4/20 0.49
RAB9A P51151 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
MAPK1 P28482 3/20 0.49
HPGD P15428 6/20 0.47
LMNA P02545 3/20 0.47
HTT P42858 2/20 0.47
USP2 O75604 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 1/20 0.42
NPC1 O15118 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20528890 1.00 PI4KB (0.60) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL21628162 0.91 PI4KB (0.73) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL29715021 0.90 PI4KB (0.62) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL23024624 0.90 PI4KB (0.62) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL21628158 0.89 PI4KB (0.59) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL21628159 0.89 PI4KB (0.59) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL23012288 0.88 PI4KB (0.53) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL29715034 0.88 PI4KB (0.53) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL23024619 0.88 PI4KB (0.53) PI4KBALDH1A1KDM4EMAPTNPSR1
SCHEMBL29714989 0.88 PI4KB (0.53) PI4KBALDH1A1KDM4EMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676485-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2026-01-14 EP claimed
WO-2024184442-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2024-09-12 WO claimed
EP-4028131-A1 HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY CUROVIR AB (SE) 2022-07-20 EP claimed
CN-110520424-B Heteroaromatic compounds for therapy 库洛维公司 2022-06-21 CN claimed
EP-4676485-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2026-01-14 EP disclosed
CN-112969703-B Compounds for the treatment of viral infections 库洛维公司 2024-11-26 CN disclosed
WO-2024184442-A1 COMPOUND AND FORMULATION FOR SYSTEMIC THERAPY BY ORAL TRANSMUCOSAL ADMINISTRATION CUROVIR AB (SE) 2024-09-12 WO disclosed